Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- ACADIA PHARMACEUTICALS INC
- Mirum Pharmaceuticals, Inc.
Updated Jul 16, 2026
Brege Laura has filed 4 SEC Form 4 filings across 4 companies in the last 90 days — selling. Lifetime open-market sales: $1.58M.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-13 | PCRX | Pacira BioSciences, Inc. | A — Grant or award | 6.4K | $0.00 | |
| 2026-06-01 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise | 8.1K | — | |
| 2025-09-11 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 1.5K | $75.07 | $112K |
| 2025-09-11 | MIRM | Mirum Pharmaceuticals, Inc. | S — Open-market sale | 15.5K | $74.34 | $1.15M |
| 2025-09-11 | MIRM | Mirum Pharmaceuticals, Inc. | M — Option exercise | 17.0K | $15.00 | $255K |
| 2025-06-04 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale | 14.4K | $21.78 | $315K |
| 2025-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise | 9.4K | — |
Brege Laura is a corporate insider — currently tracked as Insider of Mirum Pharmaceuticals, Inc. (MIRM). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 4 companies.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($1.58M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Brege Laura profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.